{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:21:39Z","timestamp":1771924899324,"version":"3.50.1"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite global recommendations for maternal tetanus-diphtheria-acellular pertussis (Tdap) vaccination to protect neonates, safety concerns persist regarding pregnancy-specific adverse events (AEs). We conducted a 20-year analysis of U.S. Vaccine Adverse Event Reporting System (VAERS) data (2005\u20132024) to characterize Tdap-associated AEs during pregnancy, with emphasis on understudied outcomes like chorioamnionitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed 870 pregnancy-related reports (128 serious) from 20,358 Tdap submissions using disproportionality analysis (Reporting Odds Ratio, ROR). Cases were identified via MedDRA-coded terms and free-text mining. Outcomes were stratified by System Organ Class (SOC), trimester, and AE seriousness. Novel signals were evaluated against product labeling and prior studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>71.9% of AEs occurred within 30 days post-vaccination. No AEs of maternal death were found. Strong safety signals stillbirth (ROR 285.77, IC 8.01), preterm delivery (ROR 196.8, IC 7.51), and fetal death (ROR 140.83, IC 7.06) were found via disproportionality from a passive surveillance system, which required further validation in active surveillance studies. Pregnancy-specific AEs represented 22.3% of significant PTs, including 6 chorioamnionitis cases with most cases having documented obstetric risk factors. Novel signals fetal hypokinesia and urinary tract infection emerged as unlabeled risks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This analysis affirms Tdap\u2019s favorable safety profile while detecting statistically significant signals that merit additional research. The low absolute risk supports continued maternal immunization, but warrants enhanced monitoring in high-risk pregnancies. The findings highlight the importance of ongoing post-marketing surveillance for evaluating vaccine safety in pregnant populations and contribute to evidence-based decision-making in clinical practice and public health policy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2025.1689560","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T06:40:52Z","timestamp":1769496052000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk signal assessment of Tdap vaccine use alone by pregnant women: An updated pharmacoepidemiological study"],"prefix":"10.3389","volume":"15","author":[{"given":"Rujuan","family":"Fan","sequence":"first","affiliation":[{"name":"Shaoxing Second Hospital","place":["Shaoxing, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijuan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Shaoxing Second Hospital","place":["Shaoxing, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Shaoxing Keqiao Women & Children's Hospital","place":["Shaoxing, Zhejiang,, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingjing","family":"Yuan","sequence":"additional","affiliation":[{"name":"Shaoxing Second Hospital","place":["Shaoxing, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1097\/AOG.0000000000002301","article-title":"Committee opinion no. 718: update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination","volume":"130","year":"2017","journal-title":"Obstetrics Gynecology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e19016","DOI":"10.1371\/journal.pone.0019016","article-title":"Bordetella pertussis infection exacerbates influenza virus infection through pertussis toxin-mediated suppression of innate immunity","volume":"6","author":"Ayala","year":"2011","journal-title":"PloS One"},{"key":"B3","first-page":"131","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012","volume":"62","year":"2013","journal-title":"MMWR. Morbidity Mortality Weekly Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1371\/currents.outbreaks.d37b61bceebae5a7a06d40a301cfa819","article-title":"Factors associated with intention to receive influenza and tetanus, diphtheria, and acellular pertussis (Tdap) vaccines during pregnancy: A focus on vaccine hesitancy and perceptions of disease severity and vaccine safety","volume":"7","author":"Chamberlain","year":"2015","journal-title":"PloS Currents"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1100617","article-title":"Real-world evidence of autoimmune hepatitis following COVID-19 vaccination: A population-based pharmacovigilance analysis","volume":"14","author":"Chen","year":"2023","journal-title":"Front. In Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1007\/s40121-023-00847-5","article-title":"Safety and clinical benefits of adacel(\u00ae) and adacel(\u00ae)-polio vaccination in pregnancy: A structured literature review","volume":"12","author":"Clark","year":"2023","journal-title":"Infect. Dis. Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1016\/j.vaccine.2015.04.097","article-title":"Chorioamnionitis following vaccination in the Vaccine Adverse Event Reporting System","volume":"33","author":"Datwani","year":"2015","journal-title":"Vaccine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"g4219","DOI":"10.1136\/bmj.g4219","article-title":"Safety of pertussis vaccination in pregnant women in UK: observational study","volume":"349","author":"Donegan","year":"2014","journal-title":"BMJ (Clinical Res. ed.)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e1475","DOI":"10.1542\/peds.2014-3925","article-title":"Strategies to decrease pertussis transmission to infants","volume":"135","author":"Forsyth","year":"2015","journal-title":"Pediatrics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"334.e331","DOI":"10.1016\/j.ajog.2010.11.024","article-title":"Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels","volume":"204","author":"Gall","year":"2011","journal-title":"Am. J. Obstetrics Gynecology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.870599","article-title":"Profiling COVID-19 vaccine adverse events by statistical and ontological analysis of VAERS case reports","volume":"13","author":"Guo","year":"2022","journal-title":"Front. In Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/cid\/ciy244","article-title":"A randomized controlled trial of the safety and immunogenicity of tetanus, diphtheria, and acellular pertussis vaccine immunization during pregnancy and subsequent infant immune response","volume":"67","author":"Halperin","year":"2018","journal-title":"Clin. Infect. Diseases: an Off. Publ. Infect. Dis. Soc. America"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1056\/NEJMoa1200850","article-title":"Waning protection after fifth dose of acellular pertussis vaccine in children","volume":"367","author":"Klein","year":"2012","journal-title":"New Engl. J. Med."},{"key":"B14","first-page":"746","article-title":"Pertussis and influenza vaccination among insured pregnant women \u2014 Wisconsin 2013-2014","volume":"64","author":"Koepke","year":"2015","journal-title":"MMWR. Morbidity Mortality Weekly Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e51007","DOI":"10.2196\/51007","article-title":"Adverse events of COVID-19 vaccines in the United States: temporal and spatial analysis","volume":"10","author":"Li","year":"2024","journal-title":"JMIR Public Health Surveill"},{"key":"B16","doi-asserted-by":"publisher","first-page":"ooaf005","DOI":"10.1093\/jamiaopen\/ooaf005","article-title":"VaxBot-HPV: a GPT-based chatbot for answering HPV vaccine-related questions","volume":"8","author":"Li","year":"2025","journal-title":"JAMIA Open"},{"key":"B17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13326-024-00318-x","article-title":"Mapping vaccine names in clinical trials to vaccine ontology using cascaded fine-tuned domain-specific language models","volume":"15","author":"Li","year":"2024","journal-title":"J. BioMed. Semantics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/14760584.2023.2292203","article-title":"Unpacking adverse events and associations post COVID-19 vaccination: a deep dive into vaccine adverse event reporting system data","volume":"23","author":"Li","year":"2024","journal-title":"Expert Rev. Vaccines"},{"key":"B19","doi-asserted-by":"publisher","first-page":"104621","DOI":"10.1016\/j.jbi.2024.104621","article-title":"Artificial intelligence-powered pharmacovigilance: A review of machine and deep learning in clinical text-based adverse drug event detection for benchmark datasets","volume":"152","author":"Li","year":"2024","journal-title":"J. BioMed. Inform"},{"key":"B20","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.vaccine.2015.10.100","article-title":"Pertussis vaccination during pregnancy in Belgium: Results of a prospective controlled cohort study","volume":"34","author":"Maertens","year":"2016","journal-title":"Vaccine"},{"key":"B21","doi-asserted-by":"publisher","first-page":"S197","DOI":"10.1093\/cid\/ciw551","article-title":"The effect of maternal pertussis immunization on infant vaccine responses to a booster pertussis-containing vaccine in Vietnam","volume":"63","author":"Maertens","year":"2016","journal-title":"Clin. Infect. Diseases: an Off. Publ. Infect. Dis. Soc. America"},{"key":"B22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nri.2017.64","article-title":"The unique immunological and microbial aspects of pregnancy","volume":"17","author":"Mor","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1097\/AOG.0000000000000862","article-title":"Pregnancy outcomes after antepartum tetanus, diphtheria, and acellular pertussis vaccination","volume":"125","author":"Morgan","year":"2015","journal-title":"Obstetrics Gynecology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/j.vaccine.2016.03.049","article-title":"Enhanced surveillance of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines in pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2011-2015","volume":"34","author":"Moro","year":"2016","journal-title":"Vaccine"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1001\/jama.2014.3633","article-title":"Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial","volume":"311","author":"Munoz","year":"2014","journal-title":"JAMA"},{"key":"B26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/jtm\/taz074","article-title":"Are all vaccines safe for the pregnant traveller? A systematic review and meta-analysis","volume":"27","author":"Nasser","year":"2020","journal-title":"J. Travel Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajog.2017.02.035","article-title":"Twenty-four percent of patients with clinical chorioamnionitis in preterm gestations have no evidence of either culture-proven intraamniotic infection or intraamniotic inflammation","volume":"216","author":"Oh","year":"2017","journal-title":"Am. J. Obstetrics Gynecology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"789","DOI":"10.2147\/CLEP.S365513","article-title":"A real-world disproportionality analysis of olaparib: data mining of the public version of FDA adverse event reporting system","volume":"14","author":"Shu","year":"2022","journal-title":"Clin. Epidemiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/PCC.0000000000000851","article-title":"Burden and outcomes of severe pertussis infection in critically ill infants","volume":"17","author":"Straney","year":"2016","journal-title":"Pediatr. Crit. Care Medicine: J. Soc. Crit. Care Med. World Fed. Pediatr. Intensive Crit. Care Societies"},{"key":"B30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s40801-021-00271-6","article-title":"Human papillomavirus vaccination and premature ovarian failure: A disproportionality analysis using the vaccine adverse event reporting system","volume":"9","author":"Tatang","year":"2022","journal-title":"Drugs - Real World Outcomes"},{"key":"B31","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12879-020-4824-3","article-title":"Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review","volume":"20","author":"Vygen-Bonnet","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2389086","DOI":"10.1080\/22221751.2024.2389086","article-title":"Rising pertussis cases and deaths in China: current trends and clinical solutions","volume":"13","author":"Yahong","year":"2024","journal-title":"Emerg. Microbes Infect."},{"key":"B33","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/S1473-3099(17)30390-0","article-title":"An update of the global burden of pertussis in children younger than 5 years: a modelling study","volume":"17","author":"Yeung","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"59.e51","DOI":"10.1016\/j.ajog.2012.05.006","article-title":"Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women","volume":"207","author":"Zheteyeva","year":"2012","journal-title":"Am. J. Obstetrics Gynecology"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1689560\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:31:51Z","timestamp":1771921911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1689560\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":34,"alternative-id":["10.3389\/fcimb.2025.1689560"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1689560","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"article-number":"1689560"}}